| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.753 | 57.257 | 58.501 | 93.054 | 127.032 | 150.382 | 212.570 | 246.200 | 332.415 | 325.529 |
| Total Income - EUR | 55.450 | 57.259 | 58.501 | 93.104 | 127.033 | 150.387 | 212.579 | 246.726 | 332.418 | 325.532 |
| Total Expenses - EUR | 34.523 | 31.373 | 37.427 | 41.488 | 45.242 | 51.353 | 65.410 | 78.192 | 137.402 | 160.120 |
| Gross Profit/Loss - EUR | 20.926 | 25.886 | 21.075 | 51.616 | 81.791 | 99.034 | 147.169 | 168.533 | 195.016 | 165.412 |
| Net Profit/Loss - EUR | 19.434 | 25.354 | 20.397 | 50.728 | 80.525 | 97.573 | 145.135 | 166.066 | 191.692 | 155.646 |
| Employees | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 3 | 3 | 3 |
Check the financial reports for the company - D&G Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 66.107 | 61.389 | 56.014 | 50.729 | 65.592 | 60.253 | 54.912 | 43.110 | 448.528 | 436.160 |
| Current Assets | 21.402 | 20.161 | 7.995 | 27.332 | 63.367 | 62.462 | 109.555 | 149.128 | 100.168 | 26.642 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 390 | 443 |
| Receivables | 3.716 | 3.680 | 3.627 | 6.943 | 9.973 | 9.232 | 46.291 | 144.725 | 90.019 | 18.211 |
| Cash | 17.685 | 16.482 | 4.369 | 20.389 | 53.394 | 53.230 | 63.264 | 4.403 | 9.759 | 7.988 |
| Shareholders Funds | 41.804 | 25.402 | 20.458 | 50.825 | 126.151 | 117.965 | 149.302 | 166.108 | 195.364 | 254.894 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.255 | 56.148 | 38.776 | 26.805 | 2.807 | 4.749 | 15.166 | 26.129 | 353.718 | 291.629 |
| Income in Advance | 13.449 | 9.269 | 4.775 | 431 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - D&G Med Srl